mosbetlucky jetmostbetmosbetlucky jetparimatchaviatoraviatoronewin casinomostbet azmosbet1 winlucky jet casino4rabetmostbet aviator login4x bet1win casinopinup login1winlucky jet crash1winpinup kzmostbet casinopinup login1win slotsmostbetpin upmostbet kz1 win1win uzmostbet casino1win4r bet1 win kzlacky jetpin up 777mosbet aviatorpin upmostbetparimatch1 win1 winpin-upmostbet onlinepin-upmostbetpin up az1 win4rabet bd1win aviatorpin up azerbaycan

Nasal vaccine being developed by Bharat Biotech for Covid-19 likely to be a game-changer for children – Read Why?

In the summer of the year 2020, the Chairman and Managing Director of India’s premier vaccine developing company, Bharat Biotech International Limited told the reporter that while efforts were on to develop an intramuscular vaccine against Covid-19, what he really would want to do is develop a vaccine that will be easy to administer like ‘polio drops’.

The analogy of polio drops drawn to a vaccine against Covid-19 at that point seemed like a tall order. However, a year later, that vision is coming close to reality and it has got the medical fraternity excited.

Dr Krishan Ella’s Bharat Biotech has started the process of screening potential clinical trial participants at four centres in India – Nagpur, Hyderabad, Patna and Chennai for their new nasal vaccine against Covid19.

World Health Organization’s chief scientist Soumya Swaminathan has said that hopefully nasal vaccines, which are being made in India, could be game changers for children. However, it may not be available this year . The hope comes amid concerns over a probable third wave of the coronavirus pandemic hitting the children.

“Some of the nasal vaccines that are going to be made in India could be game changers for children — easy to administer, will give you local immunity in the respiratory tract,” Swaminathan, a paediatrician, said in an exclusive conversation to CNN-News18.

“I am very hopeful that ultimately we’ll have vaccine for children. But that’s not going to happen this year, and we should open schools when community transmission is down. That’s what rest of the countries have done, with other precautions. And if teachers are vaccinated, that would be a big step forward,” WHO’s top scientist added.

‘There are many vaccine developers who have already started their paediatric trials, like the Pfizer vaccine is now approved for children over the age of 12 and trials in younger children are ongoing. It is expected that in a couple of months, Pfizer and Moderna vaccines will get approval. The AstraZeneca and other vaccines for younger people — there’s a slower development there because of the rare side effects noted in younger generation given the adenoviral vaccines. But certainly other classes of vaccine are coming on board,” Swaminathan said.

The Centre on Saturday said children are not immune from the infection, but stressed that the impact is minimal. ‘If children get affected by Covid, either there will be no symptoms or there will be minimal symptoms. They do not require hospitalisation generally,” Niti Aayog (health) member VK Paul said during
the press briefing of the Union health ministry.

He added that health infrastructure should be ramped up to treat Covid-19 among children, but it is most important to not let them become a part of the transmission chain in the first place.

Children account for about 3-4 per cent of hospital admission, in both India and the rest of the world, Paul said, adding special attention should be on those between the age of 10 and 12 years as they are very mobile.

Prime Minister Narendra Modi, in a recent meeting with state and district officials, had asked them to collect data on the infection transmission and severity among youth and children.

Report -Vikas Chandra Agrawal

Leave a Reply

Your email address will not be published. Required fields are marked *